Market Research Logo

Acute Kidney Injury (AKI) - Epidemiology Forecast to 2027

DelveInsight’s ‘Acute Kidney Injury (AKI) - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Acute Kidney Injury in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2016-2027

Acute Kidney Injury Epidemiology

The Acute Kidney Injury (AKI) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Acute Kidney Injury are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Acute Kidney Injury Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total incident cases, discharge diagnosed cases, stage-wise discharge diagnosed cases, risk factor associated AKI cases and renal transplantation associated delayed graft function cases) scenario of Acute Kidney Injury (AKI) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, total incident population of Acute Kidney Injury (AKI) in 7 major markets was found to be 1,516,635 in 2016.

Report Scope

• The report covers detailed overview of Acute Kidney Injury explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides the insight about the historical and forecasted patient pool of Acute Kidney Injury in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Report assesses the disease risk and burden and highlights the unmet needs of the disease
• The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report provides the segmentation of the AKI epidemiology by Stage-wise discharge diagnosed Cases i.e., Stage I, Stage II, and Stage III and risk factor associated AKI i.e. coexisting conditions and acute hospital-related factors in 7MM

Key strengths

• 10 Year Forecast of Acute Kidney Injury epidemiology
• 7MM Coverage
• Total Incident Cases of AKI
• Discharge Diagnosed cases of AKI
• Discharge Diagnosed cases according to segmentation: Stage-wise discharge diagnosed i.e., Stage I, Stage II, and Stage III
• Risk Factors Associated AKI Cases

Key assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population


1. Key Insights
2. Acute Kidney Injury Market: Overview at a Glance
2.1. Market Share Distribution of AKI in 2017
2.2. Market Share Distribution of AKI in 2027
3. Acute Kidney Injury (AKI): Disease Background and Overview
3.1. Introduction
3.2. Symptoms
3.3. Types of Acute Kidney Injury
3.4. Stages Classification
3.5. Risk Factors
3.6. Etiology
3.7. Pathophysiology
3.8. Biomarkers
3.9. Diagnosis
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. 7MM Total Incident Patient Population of AKI
4.3. 7MM Total Discharge Diagnosed Population of AKI
5. Country Wise-Epidemiology of Acute Kidney Injury
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Incident Cases of Acute Kidney Injury in the US
5.1.3. Discharge Diagnosed Cases of Acute Kidney Injury in the US
5.1.4. Stage-Wise Discharged Diagnosed Cases of Acute Kidney Injury in the US
5.1.5. Risk Factor Associated Acute Kidney Injury Cases in the US
5.1.6. Renal Transplantation Associated Delayed Graft Function Cases in the US
5.2. EU5
5.2.1. Assumptions and Rationale
5.3. Germany
5.3.1. Incident Cases of Acute Kidney Injury in Germany
5.3.2. Discharge Diagnosed Cases of Acute Kidney Injury in Germany
5.3.3. Stage-Wise Discharged Diagnosed Cases of Acute Kidney Injury in Germany
5.3.4. Risk Factor Associated Acute Kidney Injury Cases in Germany
5.3.5. Renal Transplantation Associated Delayed Graft Function Cases in Germany
5.4. France
5.4.1. Incident Cases of Acute Kidney Injury in France
5.4.2. Discharge Diagnosed Cases of Acute Kidney Injury in France
5.4.3. Stage-Wise Discharge Diagnosed Cases of Acute Kidney Injury in France
5.4.4. Risk Factor Associated Acute Kidney Injury Cases in France
5.4.5. Renal Transplantation Associated Delayed Graft Function Cases in France
5.5. Italy
5.5.1. Incident Cases of Acute Kidney Injury in Italy
5.5.2. Discharge Diagnosed Cases of Acute Kidney Injury in Italy
5.5.3. Stage-Wise Discharge Diagnosed Cases of Acute Kidney Injury in Italy
5.5.4. Risk Factor Associated Acute Kidney Injury Cases in Italy
5.5.5. Renal Transplantation Associated Delayed Graft Function Cases in Italy
5.6. Spain
5.6.1. Incident Cases of Acute Kidney Injury in Spain
5.6.2. Discharge Diagnosed Cases of Acute Kidney Injury in Spain
5.6.3. Stage-Wise Discharge Diagnosed Cases of Acute Kidney Injury in Spain
5.6.4. Risk Factor Associated Acute Kidney Injury Cases in Spain
5.6.5. Renal Transplantation Associated Delayed Graft Function Cases in Spain
5.7. United Kingdom
5.7.1. Incident Cases of Acute Kidney Injury in the UK
5.7.2. Discharge Diagnosed Incident Cases of Acute Kidney Injury in the UK
5.7.3. Stage-Wise Discharge Diagnosed Cases of Acute Kidney Injury in the UK
5.7.4. Risk Factor Associated Acute Kidney Injury Cases in the UK
5.7.5. Renal Transplantation Associated Delayed Graft Function Cases in the UK
5.8. Japan
5.8.1. Assumptions and Rationale
5.8.2. Incident Cases of Acute Kidney Injury in Japan
5.8.3. Discharge Diagnosed Cases of Acute Kidney Injury Japan
5.8.4. Stage-Wise Discharge Diagnosed Cases of Acute Kidney Injury in Japan
5.8.5. Risk Factor Associated Acute Kidney Injury Cases in Japan
5.8.6. Renal Transplantation Associated Delayed Graft Function Cases in Japan
6. Market Drivers
7. Market Barriers
8. DelveInsight Capabilities
9. Appendix
9.1. Report Methodology
10. Disclaimer
11. About DelveInsight
List of Tables and Figures
Table 1: Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE) classification
Table 2: KDIGO Criteria
Table 3: Causes of AKI: Exposures and Susceptibilities for non-specific AKI
Table 4: Biomarkers of AKI
Table 5: RIFLE Criteria for AKI
Table 6: AKIN Criteria for AKI
Table 7: KDIGO Criteria for AKI
Table 8: Total Incident Population of AKI in the 7MM (2016-2027)
Table 9: Total Discharge Diagnosed Population of AKI in the 7MM (2016-2027)
Table 10: Incident Cases of AKI in the US (2016-2027)
Table 11: Discharge Diagnosed Cases of AKI in the US (2016-2027)
Table 12: Stage Wise Discharged Diagnosed Cases of AKI in the US (2016-2027)
Table 13: Risk Factor Associated AKI Cases in the US (2016-2027)
Table 14: Renal Transplantation Associated Delayed Graft Function Cases in the US (2016-2027)
Table 15: Incident Cases of AKI in Germany (2016-2027)
Table 16: Discharge Diagnosed Cases of AKI in Germany (2016-2027)
Table 17: Stage-Wise Incident Cases of AKI in Germany (2016-2027)
Table 18: Risk Factor Associated Cases of AKI in Germany (2016-2027)
Table 19: Renal Transplantation Associated Delayed Graft Function Cases in Germany (2016- 2027)
Table 20: Incident Cases of AKI in France (2016-2027)
Table 21: Discharge Diagnosed Cases of AKI in France (2016-2027)
Table 22: Stage-Wise Discharge Diagnosed Cases of AKI in France (2016-2027)
Table 23: Risk Factor Associated AKI Cases in France (2016-2027)
Table 24: Renal Transplantation Associated Delayed Graft Function Cases in France (2016- 2027)
Table 25: Incident Cases of AKI in Italy (2016-2027)
Table 26: Discharge Diagnosed Cases of AKI in Italy (2016-2027)
Table 27: Stage-Wise Discharge Diagnosed Cases of AKI in Italy (2016-2027)
Table 28: Risk Factor Associated AKI Cases in Italy (2016-2027)
Table 29: Renal Transplantation Associated Delayed Graft Function Cases in Italy (2016-2027)
Table 30: Incident Cases of AKI in Spain (2016-2027)
Table 31: Discharge Diagnosed Cases of AKI in Spain (2016-2027)
Table 32: Stage-Wise Discharge Diagnosed Cases of AKI in Spain (2016-2027)
Table 33: Risk Factor Associated AKI Cases in Spain (2016-2027)
Table 34: Renal Transplantation Associated Delayed Graft Function Cases in Spain (2016-2027)
Table 35: Incident Cases of AKI in the UK (2016-2027)
Table 36: Discharge Diagnosed Cases of AKI in the UK (2016-2027)
Table 37: Stage-Wise Discharge Diagnosed Cases of AKI in the UK (2016-2027)
Table 38: Risk Factor Associated AKI Cases in the UK (2016-2027)
Table 39: Renal Transplantation Associated Delayed Graft Function Cases in the UK (2016-2027)
Table 40: Incident Cases of AKI in Japan (2016-2027)
Table 41: Discharge Diagnosed Cases of AKI in Japan (2016-2027)
Table 42: Stage-Wise Discharge Diagnosed Cases of AKI in Japan (2016-2027)
Table 43: Risk Factor Associated AKI Cases in Japan (2016-2027)
Table 44: Renal Transplantation Associated Delayed Graft Function Cases in Japan (2016-2027)
Figure 1: Types of Acute Kidney Injury
Figure 2: Risk factors associated with Acute Kidney Injury
Figure 3: Common Causes of AKI
Figure 4: Pathophysiology of AKI
Figure 5: Biomarkers of AKI
Figure 6: Total Incident Patient Population of AKI in the 7MM (2016-2027)
Figure 7: Total Discharge Diagnosed Population of AKI in the 7MM (2016-2027)
Figure 8: Incident Cases of AKI in the US (2016-2027)
Figure 9: Discharge Diagnosed Cases of AKI in the US (2016-2027)
Figure 10: Stage Wise Discharged Diagnosed Cases of AKI in the US (2016-2027)
Figure 11: Risk Factor Associated AKI Cases in the US (2016-2027)
Figure 12: Renal Transplantation Associated Delayed Graft Function Cases in the US (2016-2027)
Figure 13: Incident Cases of AKI in Germany (2016-2027)
Figure 14: Discharge Diagnosed Cases of AKI in Germany (2016-2027)
Figure 15: Stage-Wise Incident Cases of AKI in Germany (2016-2027)
Figure 16: Risk Factor Associated AKI Cases in Germany (2016-2027)
Figure 17: Renal Transplantation Associated Delayed Graft Function Cases in Germany (2016-2027)
Figure 18: Incident Cases of AKI in France (2016-2027)
Figure 19: Discharge Diagnosed Cases of AKI in France (2016-2027)
Figure 20: Stage-Wise Discharge Diagnosed Cases of AKI in France (2016-2027)
Figure 21: Risk Factor Associated AKI Cases in France (2016-2027)
Figure 22: Renal Transplantation Associated Delayed Graft Function Cases in France (2016-2027)
Figure 23: Incident Cases of AKI in Italy (2016-2027)
Figure 24: Discharge Diagnosed Cases of AKI in Italy (2016-2027)
Figure 25: Stage-Wise Discharge Diagnosed Cases of AKI in Italy (2016-2027)
Figure 26: Risk Factor Associated AKI Cases in Italy (2016-2027)
Figure 27: Renal Transplantation Associated Delayed Graft Function Cases in Italy (2016-2027)
Figure 28: Incident Cases of AKI in Spain (2016-2027)
Figure 29: Discharge Diagnosed Cases of AKI in Spain 2016-2027)
Figure 30: Stage-Wise Discharge Diagnosed Cases of AKI in Spain (2016-2027)
Figure 31: Risk Factor Associated AKI Cases in Spain (2016-2027)
Figure 32: Renal Transplantation Associated Delayed Graft Function Cases in Spain (2016-2027)
Figure 33: Incident Cases of AKI in the UK (2016-2027)
Figure 34: Discharge Diagnosed Cases of AKI in the UK (2016-2027)
Figure 35: Stage-Wise Discharge Diagnosed Cases of AKI the UK (2016-2027)
Figure 36: Risk Factor Associated AKI Cases in the UK (2016-2027)
Figure 37: Renal Transplantation Associated Delayed Graft Function Cases in the UK (2016-2027)
Figure 38: Incident Cases of AKI in Japan (2016-2027)
Figure 39: Discharge Diagnosed Incident Cases of AKI in Japan (2016-2027)
Figure 40: Stage-Wise Discharge Diagnosed Cases of AKI in Japan (2016-2027)
Figure 41: Risk Factor Associated AKI Cases in Japan (2016-2027)
Figure 42: Renal Transplantation Associated Delayed Graft Function Cases in Japan (2016-2027)
Figure 43: Market Drivers
Figure 44: Market Barriers

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report